APOE and Cognitive impairment: Although a previous clinical study failed to see improvement of cognitive deficits in AD patients with OS [34], it is of note that recent studies have shown that peripheral apoE metabolism could play an important role in the pathogenesis of AD; individuals with low levels of plasma apoE were more likely to develop AD in the future [6,7].